Literature DB >> 10660129

Genetic changes in sweat gland carcinomas.

M Takata1, K Hashimoto, P Mehregan, M W Lee, A Yamamoto, S Mohri, K Ohara, K Takehara.   

Abstract

The molecular pathogenesis of malignant appendageal tumors is poorly understood. Immunohistochemical staining, polymerase chain reaction (PCR)-based loss of heterozygosity (LOH) and sequencing analyses were performed in a mixed group of 21 sweat gland carcinomas. LOH was mostly confined to the chromosome arm 17p. None of the remaining 17 tumors showed LOH at any loci. Nuclear accumulation of p53 protein was observed in 3 tumors, all of which also showed LOH of 17p. One eccrine gland adenocarcinoma showed allelic loss of 17p and a Cys 176 Arg mutation in the p53 gene. The other three tumors that showed LOH of 17p, however, had wild-type p53 genes. A clear transition from benign eccrine poroma to porocarcinoma that was associated with p53 protein stabilization and allelic loss was observed in one tumor. One eccrine porocarcinoma/undifferentiated adnexal carcinoma showed prominent microsatellite instability, probably reflecting an underlying defect in DNA mismatch repair. Overexpression of erbB-2 was observed in three tumors. The low frequencies of LOH and p53 alterations in sweat gland carcinomas contrasted with the multiple genetic defects normally observed in cutaneous squamous cell carcinomas, and may be partly explained by the relative protection of cutaneous appendages from ultraviolet light and other environmental mutagens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660129     DOI: 10.1034/j.1600-0560.2000.027001030.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  8 in total

Review 1.  Sweat gland progenitors in development, homeostasis, and wound repair.

Authors:  Catherine Lu; Elaine Fuchs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 2.  Sweat Gland Tumor Microenvironment.

Authors:  Adeodatus Yuda Handaya; Sumadi Lukman Anwar; Aditya Rifqi Fauzi; Victor Agastya Pramudya Werdana
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.

Authors:  May P Chan; Komal R Plouffe; Chia-Jen Liu; Nallasivam Palanisamy; Shannon Carskadon; Lili Zhao; Rosalynn M Nazarian; Alison B Durham; Timothy M Johnson; Aleodor A Andea; Rajiv M Patel; Lori Lowe; Douglas R Fullen; Noah A Brown; Scott A Tomlins; Aaron M Udager; Paul W Harms
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

4.  Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses.

Authors:  Long P Le; Dora Dias-Santagata; Amanda C Pawlak; Arjola K Cosper; Anh Thu Nguyen; M Angelica Selim; April Deng; Nora K Horick; A John Iafrate; Martin C Mihm; Mai P Hoang
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

5.  Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.

Authors:  My Linh Thibodeau; Melika Bonakdar; Eric Zhao; Karen L Mungall; Caralyn Reisle; Wei Zhang; Morgan H Bye; Nina Thiessen; Dustin Bleile; Andrew J Mungall; Yussanne P Ma; Martin R Jones; Daniel J Renouf; Howard J Lim; Stephen Yip; Tony Ng; Cheryl Ho; Janessa Laskin; Marco A Marra; Kasmintan A Schrader; Steven J M Jones
Journal:  NPJ Precis Oncol       Date:  2018-03-19

6.  Metastatic syringoid eccrine carcinoma of the nipple.

Authors:  Pierluigi Ballardini; Guido Margutti; Massimo Pedriali; Patrizia Querzoli
Journal:  Int Med Case Rep J       Date:  2012-07-11

7.  Mutations of p53 Gene in Canine Sweat Gland Carcinomas Probably Associated with UV Radiation.

Authors:  Agnieszka Jasik; Anna Kycko; Monika Olech; Krzysztof Wyrostek; Anna Śmiech; Wojciech Łopuszyński; Iwona Otrocka-Domagała; Mateusz Mikiewicz; Izabella Dolka
Journal:  J Vet Res       Date:  2021-12-20       Impact factor: 1.744

8.  Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.

Authors:  Regina C Betz; Silke Redler; Evgeniya Denisova; Dana Westphal; Harald M Surowy; Friedegund Meier; Barbara Hutter; Julia Reifenberger; Arno Rütten; Alexander Schulz; Mildred Sergon; Mirjana Ziemer; Benedikt Brors
Journal:  Cancer Gene Ther       Date:  2021-05-27       Impact factor: 5.854

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.